ReviewTouchREVIEWS in endocrinology2024

Setmelanotide: A Melanocortin-4 Receptor Agonist for the Treatment of Severe Obesity Due to Hypothalamic Dysfunction.

Sulmaaz Qamar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.